454 related articles for article (PubMed ID: 36380168)
1. CNS Delivery of Nucleic Acid Therapeutics: Beyond the Blood-Brain Barrier and Towards Specific Cellular Targeting.
D'Souza A; Nozohouri S; Bleier BS; Amiji MM
Pharm Res; 2023 Jan; 40(1):77-105. PubMed ID: 36380168
[TBL] [Abstract][Full Text] [Related]
2. Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.
Xu L; Anchordoquy T
J Pharm Sci; 2011 Jan; 100(1):38-52. PubMed ID: 20575003
[TBL] [Abstract][Full Text] [Related]
3. Nucleic acid-based therapeutics for dermal wound healing.
Sharma P; Kumar A; Agarwal T; Dey AD; Moghaddam FD; Rahimmanesh I; Ghovvati M; Yousefiasl S; Borzacchiello A; Mohammadi A; Yella VR; Moradi O; Sharifi E
Int J Biol Macromol; 2022 Nov; 220():920-933. PubMed ID: 35987365
[TBL] [Abstract][Full Text] [Related]
4. Advances in the Design of (Nano)Formulations for Delivery of Antisense Oligonucleotides and Small Interfering RNA: Focus on the Central Nervous System.
Mendonça MCP; Kont A; Aburto MR; Cryan JF; O'Driscoll CM
Mol Pharm; 2021 Apr; 18(4):1491-1506. PubMed ID: 33734715
[TBL] [Abstract][Full Text] [Related]
5. Targeting nucleic acid-based therapeutics to tumors: Challenges and strategies for polyplexes.
Vetter VC; Wagner E
J Control Release; 2022 Jun; 346():110-135. PubMed ID: 35436520
[TBL] [Abstract][Full Text] [Related]
6. Progress in microRNA delivery.
Zhang Y; Wang Z; Gemeinhart RA
J Control Release; 2013 Dec; 172(3):962-74. PubMed ID: 24075926
[TBL] [Abstract][Full Text] [Related]
7. Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseases.
Holm A; Hansen SN; Klitgaard H; Kauppinen S
RNA Biol; 2022; 19(1):594-608. PubMed ID: 35482908
[TBL] [Abstract][Full Text] [Related]
8. Nucleic acid therapeutics for hematologic malignancies--theoretical considerations.
Opalinska JB; Kalota A; Chattopadhyaya J; Damha M; Gewirtz AM
Ann N Y Acad Sci; 2006 Oct; 1082():124-36. PubMed ID: 17145934
[TBL] [Abstract][Full Text] [Related]
9. Nucleic Acid Therapeutics in Huntington's Disease.
Singh K; Roy I
Recent Pat Biotechnol; 2019; 13(3):187-206. PubMed ID: 30747088
[TBL] [Abstract][Full Text] [Related]
10. Nucleic Acids-based Nanotherapeutics Crossing the Blood Brain Barrier.
Nafee N; Gouda N
Curr Gene Ther; 2017; 17(2):154-169. PubMed ID: 28494740
[TBL] [Abstract][Full Text] [Related]
11. Liver as a target for oligonucleotide therapeutics.
Sehgal A; Vaishnaw A; Fitzgerald K
J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
[TBL] [Abstract][Full Text] [Related]
12. Nucleic acid therapies for CNS diseases: Pathophysiology, targets, barriers, and delivery strategies.
Padmakumar S; D'Souza A; Parayath NN; Bleier BS; Amiji MM
J Control Release; 2022 Dec; 352():121-145. PubMed ID: 36252748
[TBL] [Abstract][Full Text] [Related]
13. Non-coding RNAs: Therapeutic Strategies and Delivery Systems.
Ling H
Adv Exp Med Biol; 2016; 937():229-37. PubMed ID: 27573903
[TBL] [Abstract][Full Text] [Related]
14. The infinite possibilities of RNA therapeutics.
Mollocana-Lara EC; Ni M; Agathos SN; Gonzales-Zubiate FA
J Ind Microbiol Biotechnol; 2021 Dec; 48(9-10):. PubMed ID: 34463324
[TBL] [Abstract][Full Text] [Related]
15. Nucleic acid delivery for therapeutic applications.
Gupta A; Andresen JL; Manan RS; Langer R
Adv Drug Deliv Rev; 2021 Nov; 178():113834. PubMed ID: 34492233
[TBL] [Abstract][Full Text] [Related]
16. Progress in the development of nucleic acid therapeutics for cancer.
Kalota A; Shetzline SE; Gewirtz AM
Cancer Biol Ther; 2004 Jan; 3(1):4-12. PubMed ID: 14726654
[TBL] [Abstract][Full Text] [Related]
17. Endosomal escape cell-penetrating peptides significantly enhance pharmacological effectiveness and CNS activity of systemically administered antisense oligonucleotides.
Dastpeyman M; Sharifi R; Amin A; Karas JA; Cuic B; Pan Y; Nicolazzo JA; Turner BJ; Shabanpoor F
Int J Pharm; 2021 Apr; 599():120398. PubMed ID: 33640427
[TBL] [Abstract][Full Text] [Related]
18. RNA-targeted therapeutics in cancer clinical trials: Current status and future directions.
Barata P; Sood AK; Hong DS
Cancer Treat Rev; 2016 Nov; 50():35-47. PubMed ID: 27612280
[TBL] [Abstract][Full Text] [Related]
19. Enhancing the Therapeutic Delivery of Oligonucleotides by Chemical Modification and Nanoparticle Encapsulation.
Sun Y; Zhao Y; Zhao X; Lee RJ; Teng L; Zhou C
Molecules; 2017 Oct; 22(10):. PubMed ID: 29027965
[TBL] [Abstract][Full Text] [Related]
20. Liposomal delivery of nucleic acid-based anticancer therapeutics: BP-100-1.01.
Ashizawa AT; Cortes J
Expert Opin Drug Deliv; 2015 Jul; 12(7):1107-20. PubMed ID: 25539721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
